Why glioblastoma may come back after chemo, found in mice
Original title: AAV-mediated Siglecf elimination on TAMs reverses TMZ therapy-induced T cell dysfunction in glioblastoma.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done in animals, not people. Most findings at this stage never become treatments.
The treatment was tested in mice, not in people.
The short version
In mice, chemo changed immune cells in a way that helped the tumor hide.
What was studied. Researchers studied mice with glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary given a chemo drug called temozolomide: A chemotherapy taken as a capsule, used for some brain tumors. Your team checks your blood counts while you are on it. See the glossary. They looked at single cells in the tumor to see how immune cells changed. They also looked at data from human glioblastoma tumors.
What they found. After chemo, fewer cancer cells were growing. But the T cells that fight tumors became worn out. Immune cells called macrophages shifted to a type carrying a marker named Siglec-F. That marker kept these cells from eating tumor cells. Blocking the marker in mice helped the T cells work again. In human tumor data, a matching marker showed up more in tumors that came back, and those patients did worse.
What this means, and what it doesn't
What it could mean: It offers a possible reason why glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary returns after chemo. It also points to a target that might one day make chemo work better. For now it is a lead for scientists, not a choice a patient can make.
What it doesn't mean: This does not mean a new treatment is ready. The blocking step was tested in mice, not in people. There is no drug like this a patient can ask for today. It is not a cure, and it may be years before it is tried in people, if ever.
Source: PubMed, October 19, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.